Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to ...

Ukrainian President Volodymyr Zelenskyy said Monday that all core documents on security guarantees between Ukraine, European countries and the US are ready while warning that intelligence suggests ...

WAKE COUNTY, N.C. (WTVD) -- The anticipated start of Austin Thompson's trial is less than two months away and the state filed a series of new documents in preparation. The lead prosecutor called ...

ALIGNING THE CHILDHOOD VACCINE SCHEDULE WITH INTERNATIONAL BEST PRACTICES: Today, President Donald J. Trump signed a Presidential Memorandum to begin the process to align U.S. core childhood vaccine ...

Please provide your email address to receive an email when new articles are posted on . Adding olezarsen to lipid-lowering therapy significantly reduced triglyceride levels at 6 months vs. placebo ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Researchers from Mass General Brigham have found that olezarsen-a drug designed to lower triglyceride levels-can also decrease the risk of acute pancreatitis, a potential complication in patients with ...

Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, an antisense oligonucleotide targeting apolipoprotein C-III messenger RNA, ...

Researchers from Mass General Brigham have found that olezarsen—a drug designed to lower triglyceride levels—can also decrease the risk of acute pancreatitis, a potential complication in patients with ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Dengue, caused by any one ...

All right. Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the Biotech analysts here, and it's my pleasure to introduce ...